NCT06205641

A Prospective, Multicenter, Randomized Controlled Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Influenza A

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 584 (estimated)
• Sponsor: Capital Medical University · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study is a prospective, multicenter, randomized controlled trial and aims to evaluate efficacy and safety of Xuanfei Baidu Granule in the treatment of influenza A. This study plans to enroll 584 subjects. The subjects will be randomly divided into 4 groups according to the ratio of 1:1:1:1, and they will be treated with Xuanfei Baidu Granule Placebo, Xuanfei Baidu Granule, Xuanfei Baidu Granule combined with Baloxavir Marboxil tablet.1 bag of Xuanfei Baidu Granule and Xuanfei Baidu Granule Placebo in the morning and evening, and take with boiling water for 5 days. Baloxavir Marboxil Tablet was taken orally 2 tablets, once a day for 1 day. The subjects were visited every day for 7 days after enrollment.

Conditions

• Influenza A

Interventions

Type	Name	Description
DRUG	Xuanfei Baidu Granule Placebo	Take Xuanfei Baidu Granule Placebo 1 bag in the morning and evening with boiling water for 5 days.
DRUG	Xuanfei Baidu Granule	Take Xuanfei Baidu Granule 1 bag in the morning and evening with boiling water for 5 days.
DRUG	Baloxavir Marboxil Tablet	Take Baloxavir Marboxil Tablet 2 tablets orally, once a day, for 1 day.

Timeline

• Start date: 2024-01-01
• Primary completion: 2024-06-01
• Completion: 2025-01-01
• First posted: 2024-01-16
• Last updated: 2024-01-16

Locations

1 site across 1 country: China